Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.05709207 |
2 | synaptic vesicle exocytosis (GO:0016079) | 5.80831166 |
3 | synaptic vesicle maturation (GO:0016188) | 5.68354697 |
4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.43202183 |
5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.29936905 |
6 | vocalization behavior (GO:0071625) | 5.24713549 |
7 | protein localization to synapse (GO:0035418) | 5.19657796 |
8 | glutamate secretion (GO:0014047) | 5.15518112 |
9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.11631901 |
10 | locomotory exploration behavior (GO:0035641) | 5.01714742 |
11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.97048160 |
12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.78723178 |
13 | neuron cell-cell adhesion (GO:0007158) | 4.78394812 |
14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.53492989 |
15 | regulation of synaptic vesicle transport (GO:1902803) | 4.45558723 |
16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.41396315 |
17 | neurotransmitter secretion (GO:0007269) | 4.34988828 |
18 | exploration behavior (GO:0035640) | 4.30065318 |
19 | glutamate receptor signaling pathway (GO:0007215) | 4.22460262 |
20 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.19176743 |
21 | synaptic transmission, glutamatergic (GO:0035249) | 4.18627084 |
22 | neuronal action potential propagation (GO:0019227) | 4.17502166 |
23 | positive regulation of synapse maturation (GO:0090129) | 4.16832130 |
24 | layer formation in cerebral cortex (GO:0021819) | 4.13755352 |
25 | cellular potassium ion homeostasis (GO:0030007) | 4.12297997 |
26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.11888712 |
27 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.10244895 |
28 | neuron-neuron synaptic transmission (GO:0007270) | 4.05883938 |
29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.04748103 |
30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.04714743 |
31 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.02158401 |
32 | neuronal ion channel clustering (GO:0045161) | 3.98550503 |
33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.95285432 |
34 | establishment of mitochondrion localization (GO:0051654) | 3.84438306 |
35 | regulation of synapse structural plasticity (GO:0051823) | 3.83382273 |
36 | long-term memory (GO:0007616) | 3.80300072 |
37 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.75744273 |
38 | response to pheromone (GO:0019236) | 3.75511168 |
39 | neuron recognition (GO:0008038) | 3.72778552 |
40 | gamma-aminobutyric acid transport (GO:0015812) | 3.67161511 |
41 | neurotransmitter transport (GO:0006836) | 3.65691231 |
42 | sodium ion export (GO:0071436) | 3.65396444 |
43 | dendritic spine morphogenesis (GO:0060997) | 3.64857921 |
44 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.63857713 |
45 | positive regulation of membrane potential (GO:0045838) | 3.61887421 |
46 | mechanosensory behavior (GO:0007638) | 3.61251627 |
47 | nucleobase catabolic process (GO:0046113) | 3.59229920 |
48 | regulation of postsynaptic membrane potential (GO:0060078) | 3.58430126 |
49 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.58353776 |
50 | regulation of neurotransmitter secretion (GO:0046928) | 3.56167133 |
51 | innervation (GO:0060384) | 3.53794658 |
52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.53459048 |
53 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.48243511 |
54 | * synaptic vesicle endocytosis (GO:0048488) | 3.44574322 |
55 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.43186749 |
56 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.42902643 |
57 | proline transport (GO:0015824) | 3.42316299 |
58 | presynaptic membrane assembly (GO:0097105) | 3.40408369 |
59 | long-term synaptic potentiation (GO:0060291) | 3.37620598 |
60 | postsynaptic membrane organization (GO:0001941) | 3.37421465 |
61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.37156089 |
62 | axonal fasciculation (GO:0007413) | 3.36799006 |
63 | presynaptic membrane organization (GO:0097090) | 3.35429864 |
64 | membrane hyperpolarization (GO:0060081) | 3.33957020 |
65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.33605014 |
66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33370411 |
67 | regulation of synaptic plasticity (GO:0048167) | 3.31821665 |
68 | activation of protein kinase A activity (GO:0034199) | 3.29496676 |
69 | regulation of neurotransmitter levels (GO:0001505) | 3.27213911 |
70 | regulation of synapse maturation (GO:0090128) | 3.27177315 |
71 | regulation of vesicle fusion (GO:0031338) | 3.27130895 |
72 | transmission of nerve impulse (GO:0019226) | 3.26210793 |
73 | regulation of neurotransmitter transport (GO:0051588) | 3.25953258 |
74 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.23872049 |
75 | dendrite morphogenesis (GO:0048813) | 3.20393294 |
76 | L-amino acid import (GO:0043092) | 3.19886879 |
77 | positive regulation of synapse assembly (GO:0051965) | 3.17890461 |
78 | cell communication by electrical coupling (GO:0010644) | 3.17500863 |
79 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.16976845 |
80 | cell migration in hindbrain (GO:0021535) | 3.16807787 |
81 | behavioral defense response (GO:0002209) | 3.15906784 |
82 | behavioral fear response (GO:0001662) | 3.15906784 |
83 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.15415951 |
84 | cerebellar granule cell differentiation (GO:0021707) | 3.15315848 |
85 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.14794361 |
86 | synapse assembly (GO:0007416) | 3.14324078 |
87 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.13516244 |
88 | membrane depolarization during action potential (GO:0086010) | 3.12783754 |
89 | neurofilament cytoskeleton organization (GO:0060052) | 3.12181605 |
90 | mating behavior (GO:0007617) | 3.11008523 |
91 | membrane depolarization (GO:0051899) | 3.09252309 |
92 | neuromuscular synaptic transmission (GO:0007274) | 3.08769574 |
93 | dendritic spine organization (GO:0097061) | 3.07152932 |
94 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.06221702 |
95 | neuromuscular process controlling posture (GO:0050884) | 3.05276668 |
96 | neuromuscular process controlling balance (GO:0050885) | 3.03234137 |
97 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.02799069 |
98 | central nervous system myelination (GO:0022010) | 3.00845390 |
99 | axon ensheathment in central nervous system (GO:0032291) | 3.00845390 |
100 | * synaptic transmission (GO:0007268) | 3.00642325 |
101 | potassium ion homeostasis (GO:0055075) | 2.98069978 |
102 | fear response (GO:0042596) | 2.97629112 |
103 | positive regulation of dendritic spine development (GO:0060999) | 2.97219853 |
104 | adult walking behavior (GO:0007628) | 2.97207186 |
105 | positive regulation of neurotransmitter transport (GO:0051590) | 2.97195637 |
106 | startle response (GO:0001964) | 2.96623551 |
107 | * synaptic vesicle transport (GO:0048489) | 2.96617369 |
108 | * establishment of synaptic vesicle localization (GO:0097480) | 2.96617369 |
109 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.96370006 |
110 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.95221029 |
111 | response to auditory stimulus (GO:0010996) | 2.95216620 |
112 | potassium ion import (GO:0010107) | 2.95126358 |
113 | * learning (GO:0007612) | 2.94964608 |
114 | retinal cone cell development (GO:0046549) | 2.94482305 |
115 | response to histamine (GO:0034776) | 2.92427115 |
116 | auditory behavior (GO:0031223) | 2.91685418 |
117 | regulation of synaptic transmission (GO:0050804) | 2.91493445 |
118 | positive regulation of synaptic transmission (GO:0050806) | 2.91300496 |
119 | regulation of dendritic spine development (GO:0060998) | 2.88817982 |
120 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.87697696 |
121 | mitochondrion transport along microtubule (GO:0047497) | 2.87697696 |
122 | behavioral response to cocaine (GO:0048148) | 2.86547551 |
123 | C4-dicarboxylate transport (GO:0015740) | 2.86185318 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.46057058 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.92358826 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14482752 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07270520 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05932772 |
6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.81555719 |
7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68350630 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67937303 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67937303 |
10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.60344768 |
11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55731506 |
12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53669204 |
13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51160492 |
14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49384866 |
15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.47838145 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39246119 |
17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.34981895 |
18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.34193725 |
19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32055201 |
20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31769157 |
21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.30489552 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.25745079 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.22028821 |
24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.19992673 |
25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.12097555 |
26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.07853667 |
27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.92603274 |
28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91966554 |
29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.91195852 |
30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80089342 |
31 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77159396 |
32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70424152 |
33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69382069 |
34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66538831 |
35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62146379 |
36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55373484 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54448271 |
38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47893605 |
39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47231261 |
40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44892123 |
41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43008517 |
42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42899897 |
43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42678216 |
44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40747852 |
45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39634698 |
46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.36713393 |
47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36033858 |
48 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.34534330 |
49 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32335306 |
50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32241187 |
51 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30973899 |
52 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30428619 |
53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30018686 |
54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27787407 |
55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27109146 |
56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25858203 |
57 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.25377224 |
58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25352495 |
59 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24723960 |
60 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.24712148 |
61 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23578812 |
62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22967959 |
63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21242175 |
64 | * AR_19668381_ChIP-Seq_PC3_Human | 1.20525749 |
65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18008662 |
66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17392314 |
67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15657109 |
68 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.13952413 |
69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13570353 |
70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11979573 |
71 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11919020 |
72 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11566999 |
73 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09145988 |
74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08647536 |
75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07518880 |
76 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07500571 |
77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06903155 |
78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05199962 |
79 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04997921 |
80 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04074538 |
81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02642974 |
82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02363909 |
83 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.01699694 |
84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01511159 |
85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01418091 |
86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01296299 |
87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99712596 |
88 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99136746 |
89 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.99016496 |
90 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98336706 |
91 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97618224 |
92 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96351669 |
93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96173444 |
94 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95858595 |
95 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95858595 |
96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95607146 |
97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95415256 |
98 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95286623 |
99 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92920215 |
100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91950698 |
101 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91645698 |
102 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90598769 |
103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90598769 |
104 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90492965 |
105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90093464 |
106 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89780582 |
107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89716802 |
108 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89613797 |
109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89425880 |
110 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89349955 |
111 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.87943486 |
112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87516840 |
113 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87291760 |
114 | JUN_21703547_ChIP-Seq_K562_Human | 0.87228369 |
115 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86913550 |
116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86722935 |
117 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85691209 |
118 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.84961344 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.86109116 |
2 | MP0003880_abnormal_central_pattern | 4.63229259 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.96622866 |
4 | MP0004270_analgesia | 3.67890075 |
5 | * MP0002063_abnormal_learning/memory/cond | 3.16934646 |
6 | * MP0009745_abnormal_behavioral_response | 3.15559985 |
7 | MP0009046_muscle_twitch | 3.12559018 |
8 | * MP0002064_seizures | 3.07220689 |
9 | MP0005423_abnormal_somatic_nervous | 2.96953443 |
10 | MP0001968_abnormal_touch/_nociception | 2.96841017 |
11 | MP0002734_abnormal_mechanical_nocicepti | 2.77197142 |
12 | MP0002272_abnormal_nervous_system | 2.72720774 |
13 | MP0002572_abnormal_emotion/affect_behav | 2.70732994 |
14 | MP0001486_abnormal_startle_reflex | 2.61414277 |
15 | MP0002735_abnormal_chemical_nociception | 2.56642086 |
16 | MP0002736_abnormal_nociception_after | 2.39213508 |
17 | MP0005551_abnormal_eye_electrophysiolog | 2.16769489 |
18 | MP0001501_abnormal_sleep_pattern | 2.10029369 |
19 | MP0001440_abnormal_grooming_behavior | 2.08713942 |
20 | MP0002067_abnormal_sensory_capabilities | 2.06582894 |
21 | MP0001970_abnormal_pain_threshold | 2.00027917 |
22 | MP0002184_abnormal_innervation | 1.99893316 |
23 | MP0002733_abnormal_thermal_nociception | 1.99693447 |
24 | MP0000778_abnormal_nervous_system | 1.98090009 |
25 | MP0002822_catalepsy | 1.92487314 |
26 | MP0003329_amyloid_beta_deposits | 1.91723823 |
27 | MP0001984_abnormal_olfaction | 1.87495555 |
28 | MP0008569_lethality_at_weaning | 1.83387119 |
29 | MP0009780_abnormal_chondrocyte_physiolo | 1.74374644 |
30 | MP0006276_abnormal_autonomic_nervous | 1.71974865 |
31 | MP0002557_abnormal_social/conspecific_i | 1.70470371 |
32 | MP0000955_abnormal_spinal_cord | 1.67414033 |
33 | * MP0004811_abnormal_neuron_physiology | 1.66340036 |
34 | MP0005386_behavior/neurological_phenoty | 1.65597899 |
35 | MP0004924_abnormal_behavior | 1.65597899 |
36 | MP0004858_abnormal_nervous_system | 1.64238672 |
37 | MP0003121_genomic_imprinting | 1.64153629 |
38 | MP0002882_abnormal_neuron_morphology | 1.61145071 |
39 | MP0001502_abnormal_circadian_rhythm | 1.54219127 |
40 | MP0004885_abnormal_endolymph | 1.53933011 |
41 | MP0003879_abnormal_hair_cell | 1.51877358 |
42 | MP0008877_abnormal_DNA_methylation | 1.51189389 |
43 | MP0004142_abnormal_muscle_tone | 1.44628033 |
44 | MP0002066_abnormal_motor_capabilities/c | 1.44357530 |
45 | MP0005646_abnormal_pituitary_gland | 1.44163547 |
46 | MP0001529_abnormal_vocalization | 1.42303481 |
47 | MP0002909_abnormal_adrenal_gland | 1.40139753 |
48 | MP0005645_abnormal_hypothalamus_physiol | 1.39707468 |
49 | MP0006072_abnormal_retinal_apoptosis | 1.38511812 |
50 | MP0002229_neurodegeneration | 1.32484038 |
51 | MP0002102_abnormal_ear_morphology | 1.32225026 |
52 | MP0010386_abnormal_urinary_bladder | 1.31080951 |
53 | MP0003787_abnormal_imprinting | 1.30413476 |
54 | MP0003122_maternal_imprinting | 1.30097387 |
55 | MP0002090_abnormal_vision | 1.28115923 |
56 | MP0003633_abnormal_nervous_system | 1.27653222 |
57 | MP0001905_abnormal_dopamine_level | 1.26202506 |
58 | MP0004145_abnormal_muscle_electrophysio | 1.19854949 |
59 | MP0002152_abnormal_brain_morphology | 1.15891358 |
60 | MP0003123_paternal_imprinting | 1.15618461 |
61 | MP0001188_hyperpigmentation | 1.15070068 |
62 | MP0004742_abnormal_vestibular_system | 1.14736450 |
63 | MP0003631_nervous_system_phenotype | 1.13820567 |
64 | MP0005253_abnormal_eye_physiology | 1.11790005 |
65 | MP0002752_abnormal_somatic_nervous | 1.10757667 |
66 | MP0008789_abnormal_olfactory_epithelium | 1.05864917 |
67 | MP0003634_abnormal_glial_cell | 1.05472460 |
68 | MP0000751_myopathy | 1.01249769 |
69 | MP0000920_abnormal_myelination | 1.00676053 |
70 | MP0004233_abnormal_muscle_weight | 0.99636851 |
71 | MP0005499_abnormal_olfactory_system | 0.99162788 |
72 | MP0005394_taste/olfaction_phenotype | 0.99162788 |
73 | MP0000631_abnormal_neuroendocrine_gland | 0.97576260 |
74 | MP0001963_abnormal_hearing_physiology | 0.96549981 |
75 | MP0002638_abnormal_pupillary_reflex | 0.93148748 |
76 | MP0002069_abnormal_eating/drinking_beha | 0.92145153 |
77 | MP0003632_abnormal_nervous_system | 0.91066483 |
78 | MP0005187_abnormal_penis_morphology | 0.88784292 |
79 | MP0008872_abnormal_physiological_respon | 0.86994259 |
80 | MP0004133_heterotaxia | 0.83854442 |
81 | MP0001177_atelectasis | 0.82006024 |
82 | MP0005195_abnormal_posterior_eye | 0.81949258 |
83 | MP0004085_abnormal_heartbeat | 0.81738412 |
84 | MP0004215_abnormal_myocardial_fiber | 0.81341957 |
85 | MP0000566_synostosis | 0.80078960 |
86 | MP0000604_amyloidosis | 0.77704631 |
87 | MP0001299_abnormal_eye_distance/ | 0.76466184 |
88 | MP0003938_abnormal_ear_development | 0.76267369 |
89 | MP0004147_increased_porphyrin_level | 0.74937756 |
90 | MP0003137_abnormal_impulse_conducting | 0.73968136 |
91 | MP0002837_dystrophic_cardiac_calcinosis | 0.72955787 |
92 | MP0001485_abnormal_pinna_reflex | 0.70817288 |
93 | MP0003690_abnormal_glial_cell | 0.70690219 |
94 | MP0001986_abnormal_taste_sensitivity | 0.70324607 |
95 | MP0000013_abnormal_adipose_tissue | 0.70153186 |
96 | MP0003890_abnormal_embryonic-extraembry | 0.69461922 |
97 | MP0008874_decreased_physiological_sensi | 0.68814861 |
98 | MP0005535_abnormal_body_temperature | 0.67791028 |
99 | MP0003283_abnormal_digestive_organ | 0.65498458 |
100 | MP0003119_abnormal_digestive_system | 0.64777874 |
101 | MP0000049_abnormal_middle_ear | 0.64481079 |
102 | MP0002751_abnormal_autonomic_nervous | 0.63875773 |
103 | MP0003861_abnormal_nervous_system | 0.63756636 |
104 | MP0004043_abnormal_pH_regulation | 0.62413154 |
105 | MP0005623_abnormal_meninges_morphology | 0.62026244 |
106 | MP0000026_abnormal_inner_ear | 0.60705149 |
107 | MP0001664_abnormal_digestion | 0.59619385 |
108 | MP0002653_abnormal_ependyma_morphology | 0.59530657 |
109 | MP0001943_abnormal_respiration | 0.56748303 |
110 | MP0008961_abnormal_basal_metabolism | 0.55495935 |
111 | MP0006292_abnormal_olfactory_placode | 0.55108315 |
112 | MP0000569_abnormal_digit_pigmentation | 0.54796128 |
113 | MP0010769_abnormal_survival | 0.54659517 |
114 | MP0002082_postnatal_lethality | 0.53510821 |
115 | MP0010770_preweaning_lethality | 0.53510821 |
116 | MP0002234_abnormal_pharynx_morphology | 0.52099770 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.72718904 |
2 | Myokymia (HP:0002411) | 6.42253740 |
3 | Visual hallucinations (HP:0002367) | 5.19323414 |
4 | Focal seizures (HP:0007359) | 5.16729275 |
5 | Epileptic encephalopathy (HP:0200134) | 5.15466131 |
6 | Progressive cerebellar ataxia (HP:0002073) | 4.59760521 |
7 | Febrile seizures (HP:0002373) | 4.57309067 |
8 | Atonic seizures (HP:0010819) | 4.46601207 |
9 | Absence seizures (HP:0002121) | 4.17627019 |
10 | Dialeptic seizures (HP:0011146) | 3.78790505 |
11 | Action tremor (HP:0002345) | 3.73282120 |
12 | Supranuclear gaze palsy (HP:0000605) | 3.72029198 |
13 | Generalized tonic-clonic seizures (HP:0002069) | 3.58365113 |
14 | Congenital stationary night blindness (HP:0007642) | 3.51960394 |
15 | Ankle clonus (HP:0011448) | 3.32772856 |
16 | Gaze-evoked nystagmus (HP:0000640) | 3.25056009 |
17 | Dysdiadochokinesis (HP:0002075) | 3.22338214 |
18 | Mutism (HP:0002300) | 3.17986750 |
19 | Broad-based gait (HP:0002136) | 3.16116402 |
20 | Dysmetria (HP:0001310) | 3.04952793 |
21 | Truncal ataxia (HP:0002078) | 3.03557086 |
22 | Depression (HP:0000716) | 3.03378136 |
23 | Central scotoma (HP:0000603) | 2.94244911 |
24 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.92510076 |
25 | Neurofibrillary tangles (HP:0002185) | 2.92083420 |
26 | Hyperventilation (HP:0002883) | 2.90808674 |
27 | Abnormal eating behavior (HP:0100738) | 2.89498149 |
28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.86853374 |
29 | Poor eye contact (HP:0000817) | 2.80933117 |
30 | Cerebral inclusion bodies (HP:0100314) | 2.80081875 |
31 | Amblyopia (HP:0000646) | 2.79508624 |
32 | Hemiparesis (HP:0001269) | 2.71565389 |
33 | Spastic gait (HP:0002064) | 2.71547960 |
34 | Scanning speech (HP:0002168) | 2.70393154 |
35 | Epileptiform EEG discharges (HP:0011182) | 2.66184990 |
36 | Anxiety (HP:0000739) | 2.65929002 |
37 | Excessive salivation (HP:0003781) | 2.65051551 |
38 | Drooling (HP:0002307) | 2.65051551 |
39 | Genetic anticipation (HP:0003743) | 2.63290383 |
40 | Abnormality of the labia minora (HP:0012880) | 2.63269784 |
41 | Pheochromocytoma (HP:0002666) | 2.60712263 |
42 | Sleep apnea (HP:0010535) | 2.60661627 |
43 | Diplopia (HP:0000651) | 2.60401312 |
44 | Abnormality of binocular vision (HP:0011514) | 2.60401312 |
45 | Abnormality of the corticospinal tract (HP:0002492) | 2.60195882 |
46 | EEG with generalized epileptiform discharges (HP:0011198) | 2.59510570 |
47 | Abnormality of macular pigmentation (HP:0008002) | 2.57002065 |
48 | Abnormality of the lower motor neuron (HP:0002366) | 2.56504452 |
49 | Abnormal social behavior (HP:0012433) | 2.55663798 |
50 | Impaired social interactions (HP:0000735) | 2.55663798 |
51 | Postural instability (HP:0002172) | 2.53828744 |
52 | Peripheral hypomyelination (HP:0007182) | 2.47007466 |
53 | Urinary urgency (HP:0000012) | 2.44610501 |
54 | Insidious onset (HP:0003587) | 2.44068663 |
55 | Termporal pattern (HP:0011008) | 2.44068663 |
56 | Polyphagia (HP:0002591) | 2.43983656 |
57 | Progressive inability to walk (HP:0002505) | 2.42007388 |
58 | Intention tremor (HP:0002080) | 2.41471762 |
59 | Limb dystonia (HP:0002451) | 2.40556745 |
60 | Hypsarrhythmia (HP:0002521) | 2.35541202 |
61 | Impaired smooth pursuit (HP:0007772) | 2.34353538 |
62 | Absent speech (HP:0001344) | 2.34123566 |
63 | Optic nerve hypoplasia (HP:0000609) | 2.33238851 |
64 | Gait imbalance (HP:0002141) | 2.32919892 |
65 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.29628639 |
66 | Cerebral hypomyelination (HP:0006808) | 2.28123170 |
67 | Megalencephaly (HP:0001355) | 2.24715984 |
68 | Fetal akinesia sequence (HP:0001989) | 2.24593985 |
69 | Neuroendocrine neoplasm (HP:0100634) | 2.23454218 |
70 | Bradykinesia (HP:0002067) | 2.22568976 |
71 | Lower limb muscle weakness (HP:0007340) | 2.17620128 |
72 | Torticollis (HP:0000473) | 2.17191604 |
73 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.15839028 |
74 | Lissencephaly (HP:0001339) | 2.15359067 |
75 | Spastic tetraplegia (HP:0002510) | 2.11439011 |
76 | Generalized myoclonic seizures (HP:0002123) | 2.10659713 |
77 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09737330 |
78 | Hemiplegia (HP:0002301) | 2.06823439 |
79 | Ulnar claw (HP:0001178) | 2.06627718 |
80 | Inability to walk (HP:0002540) | 2.06393511 |
81 | Focal dystonia (HP:0004373) | 2.06018526 |
82 | Type II lissencephaly (HP:0007260) | 2.05463820 |
83 | Papilledema (HP:0001085) | 2.03372811 |
84 | Genital tract atresia (HP:0001827) | 2.01910496 |
85 | Specific learning disability (HP:0001328) | 2.01253304 |
86 | Vaginal atresia (HP:0000148) | 2.00879131 |
87 | Akinesia (HP:0002304) | 1.99919165 |
88 | CNS hypomyelination (HP:0003429) | 1.98751120 |
89 | Scotoma (HP:0000575) | 1.98702846 |
90 | Delusions (HP:0000746) | 1.98011879 |
91 | Impaired vibratory sensation (HP:0002495) | 1.96636627 |
92 | Stereotypic behavior (HP:0000733) | 1.96451378 |
93 | Agitation (HP:0000713) | 1.96164638 |
94 | Amyotrophic lateral sclerosis (HP:0007354) | 1.96075399 |
95 | Split foot (HP:0001839) | 1.92963035 |
96 | Gait ataxia (HP:0002066) | 1.92445355 |
97 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.92046333 |
98 | Ventricular fibrillation (HP:0001663) | 1.91493899 |
99 | Retinal dysplasia (HP:0007973) | 1.91119513 |
100 | Nephronophthisis (HP:0000090) | 1.90926482 |
101 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.90245994 |
102 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.89464118 |
103 | Hypoplasia of the brainstem (HP:0002365) | 1.89464118 |
104 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.88831185 |
105 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.88831185 |
106 | Poor suck (HP:0002033) | 1.87374006 |
107 | Dysmetric saccades (HP:0000641) | 1.87324560 |
108 | Neuronal loss in central nervous system (HP:0002529) | 1.87154471 |
109 | Status epilepticus (HP:0002133) | 1.86918343 |
110 | Decreased central vision (HP:0007663) | 1.85812550 |
111 | Congenital primary aphakia (HP:0007707) | 1.85535161 |
112 | Failure to thrive in infancy (HP:0001531) | 1.85142365 |
113 | Incomplete penetrance (HP:0003829) | 1.82828063 |
114 | Clonus (HP:0002169) | 1.81380622 |
115 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.81150754 |
116 | True hermaphroditism (HP:0010459) | 1.79694360 |
117 | Abnormal hair whorl (HP:0010721) | 1.79165055 |
118 | Craniofacial dystonia (HP:0012179) | 1.78380993 |
119 | Molar tooth sign on MRI (HP:0002419) | 1.78291859 |
120 | Abnormality of midbrain morphology (HP:0002418) | 1.78291859 |
121 | Pancreatic fibrosis (HP:0100732) | 1.77769029 |
122 | Medial flaring of the eyebrow (HP:0010747) | 1.77722405 |
123 | Hypoventilation (HP:0002791) | 1.77100381 |
124 | Abnormality of salivation (HP:0100755) | 1.75632902 |
125 | Dyskinesia (HP:0100660) | 1.72084545 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.97967858 |
2 | MAP3K9 | 3.70691881 |
3 | MARK1 | 3.70365016 |
4 | EPHA4 | 3.25326512 |
5 | MAP3K4 | 3.04722073 |
6 | MINK1 | 2.86774111 |
7 | MAP2K7 | 2.52842236 |
8 | PAK6 | 2.50375858 |
9 | CASK | 2.40026940 |
10 | PRPF4B | 2.33299254 |
11 | DAPK2 | 2.19242432 |
12 | NTRK2 | 2.01718931 |
13 | MAP3K12 | 1.95095432 |
14 | KSR2 | 1.89961868 |
15 | NTRK1 | 1.81628391 |
16 | MAP2K4 | 1.80672831 |
17 | PRKD3 | 1.70567407 |
18 | PLK2 | 1.64010202 |
19 | CDK19 | 1.60659430 |
20 | TNIK | 1.57156139 |
21 | GRK5 | 1.57054590 |
22 | KSR1 | 1.56581070 |
23 | CAMKK1 | 1.50722084 |
24 | PNCK | 1.48579534 |
25 | * CDK5 | 1.48135497 |
26 | MAPK13 | 1.45410793 |
27 | PHKG2 | 1.40694425 |
28 | PHKG1 | 1.40694425 |
29 | TRIM28 | 1.33151253 |
30 | DAPK1 | 1.31859194 |
31 | UHMK1 | 1.31635758 |
32 | PRKCG | 1.29497655 |
33 | MAP4K2 | 1.28735878 |
34 | ARAF | 1.27273348 |
35 | STK38 | 1.27189185 |
36 | RIPK4 | 1.23456155 |
37 | OXSR1 | 1.18310154 |
38 | SIK2 | 1.12124418 |
39 | FES | 1.09413863 |
40 | SGK223 | 1.08825041 |
41 | SGK494 | 1.08825041 |
42 | CAMK2A | 1.04393177 |
43 | MAP3K13 | 1.01815089 |
44 | TYRO3 | 0.96881225 |
45 | CAMKK2 | 0.96631356 |
46 | PAK3 | 0.91783213 |
47 | LATS2 | 0.91617177 |
48 | * CDK14 | 0.89273300 |
49 | CAMK2B | 0.87748314 |
50 | * CDK18 | 0.87049678 |
51 | MAP3K2 | 0.85181858 |
52 | * CDK15 | 0.83892860 |
53 | CSNK1A1L | 0.83552017 |
54 | CAMK1 | 0.83116519 |
55 | CSNK1G2 | 0.80149423 |
56 | CSNK1G1 | 0.79102879 |
57 | BMPR1B | 0.76743525 |
58 | NEK1 | 0.76667708 |
59 | NME1 | 0.76162757 |
60 | STK11 | 0.73499599 |
61 | MARK2 | 0.73014070 |
62 | PINK1 | 0.72235720 |
63 | * CDK11A | 0.71638695 |
64 | STK39 | 0.71418932 |
65 | FGFR2 | 0.71235252 |
66 | CAMK2D | 0.70884610 |
67 | CAMK4 | 0.69882893 |
68 | BCR | 0.68946010 |
69 | LMTK2 | 0.68166124 |
70 | TNK2 | 0.68072163 |
71 | PTK2B | 0.67120099 |
72 | PRKCH | 0.66419540 |
73 | RET | 0.65850292 |
74 | PRKCE | 0.64202404 |
75 | PKN1 | 0.63263793 |
76 | WNK1 | 0.61844991 |
77 | SGK2 | 0.60887922 |
78 | BRSK1 | 0.60690266 |
79 | SGK1 | 0.60499190 |
80 | RAF1 | 0.60365029 |
81 | FER | 0.59689704 |
82 | ROCK2 | 0.59373410 |
83 | CCNB1 | 0.58792466 |
84 | * DYRK1A | 0.58749971 |
85 | PRKCZ | 0.56405503 |
86 | FRK | 0.54695407 |
87 | FGR | 0.54442970 |
88 | BMPR2 | 0.54349570 |
89 | TAOK1 | 0.53510079 |
90 | INSRR | 0.53116620 |
91 | WNK3 | 0.51152296 |
92 | CAMK2G | 0.49708660 |
93 | DYRK3 | 0.48220200 |
94 | AKT3 | 0.48214032 |
95 | RPS6KA3 | 0.46760012 |
96 | EPHB2 | 0.46751432 |
97 | NEK6 | 0.46689350 |
98 | FYN | 0.46271657 |
99 | SIK3 | 0.45771602 |
100 | MAP3K11 | 0.45509247 |
101 | CAMK1G | 0.45255949 |
102 | PDK1 | 0.44415245 |
103 | LIMK1 | 0.44281516 |
104 | MAP3K1 | 0.43910755 |
105 | SGK3 | 0.43618063 |
106 | CSNK1D | 0.43592475 |
107 | PRKACA | 0.43464843 |
108 | ALK | 0.42264033 |
109 | WNK4 | 0.42235461 |
110 | CSNK1E | 0.41522715 |
111 | PRKG1 | 0.41424603 |
112 | CDC42BPA | 0.41222059 |
113 | DYRK2 | 0.41057885 |
114 | CSNK1G3 | 0.39970900 |
115 | ERBB2 | 0.39922300 |
116 | PDPK1 | 0.39319069 |
117 | * MAPK10 | 0.38974424 |
118 | CSNK1A1 | 0.38690179 |
119 | MAP3K7 | 0.37814756 |
120 | ADRBK2 | 0.36235416 |
121 | ERBB3 | 0.36218761 |
122 | EPHA3 | 0.34630403 |
123 | PRKACB | 0.32608510 |
124 | PRKCA | 0.32436367 |
125 | PRKAA1 | 0.30130982 |
126 | PRKCB | 0.27963009 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.02721938 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.70327215 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.02038233 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.91832503 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.76612308 |
6 | Morphine addiction_Homo sapiens_hsa05032 | 2.67942541 |
7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.59432609 |
8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.54820646 |
9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.43088100 |
10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23260513 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16679389 |
12 | Salivary secretion_Homo sapiens_hsa04970 | 2.14429063 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14126007 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 2.04883339 |
15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96320607 |
16 | Taste transduction_Homo sapiens_hsa04742 | 1.82363107 |
17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.81410865 |
18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80468351 |
19 | Phototransduction_Homo sapiens_hsa04744 | 1.76719676 |
20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73807030 |
21 | Long-term depression_Homo sapiens_hsa04730 | 1.72441684 |
22 | Renin secretion_Homo sapiens_hsa04924 | 1.69995303 |
23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68901066 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62885650 |
25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.62645918 |
26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49947599 |
27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.47829885 |
28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.39528024 |
29 | Gap junction_Homo sapiens_hsa04540 | 1.38415419 |
30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32143533 |
31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31950605 |
32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29779744 |
33 | Axon guidance_Homo sapiens_hsa04360 | 1.22225115 |
34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20407829 |
35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.18953878 |
36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15204955 |
37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14078432 |
38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10778038 |
39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10766023 |
40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07091848 |
41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06790931 |
42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02710800 |
43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00831308 |
44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99819716 |
45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96690676 |
46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93776227 |
47 | Melanogenesis_Homo sapiens_hsa04916 | 0.93549293 |
48 | Glioma_Homo sapiens_hsa05214 | 0.93039041 |
49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83621027 |
50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81297635 |
51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80806048 |
52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80247174 |
53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79428858 |
54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77637573 |
55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77611420 |
56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77351615 |
57 | Huntingtons disease_Homo sapiens_hsa05016 | 0.75944873 |
58 | Protein export_Homo sapiens_hsa03060 | 0.70268405 |
59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68223749 |
60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66236629 |
61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65219709 |
62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65066732 |
63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64389480 |
64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59135784 |
65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59073739 |
66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58764339 |
67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57371208 |
68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56830112 |
69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.56827794 |
70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56370640 |
71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55477923 |
72 | Alcoholism_Homo sapiens_hsa05034 | 0.53730153 |
73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52246009 |
74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52233995 |
75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52092171 |
76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51806161 |
77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50548476 |
78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47243597 |
79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47136139 |
80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46642181 |
81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46265346 |
82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45687222 |
83 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45253790 |
84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44988119 |
85 | * Endocytosis_Homo sapiens_hsa04144 | 0.44730625 |
86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44612260 |
87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44607871 |
88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43898629 |
89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43468815 |
90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41972684 |
91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40988405 |
92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40456489 |
93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39413761 |
94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38629365 |
95 | Bile secretion_Homo sapiens_hsa04976 | 0.38509348 |
96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38026389 |
97 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36533689 |
98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36044429 |
99 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.34365129 |
100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33741924 |
101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33361455 |
102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32939749 |
103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32593969 |
104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31591350 |
105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31269198 |
106 | Prion diseases_Homo sapiens_hsa05020 | 0.30649025 |
107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29455416 |
108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28878275 |
109 | Tight junction_Homo sapiens_hsa04530 | 0.28543678 |
110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28186869 |
111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27232447 |
112 | Parkinsons disease_Homo sapiens_hsa05012 | 0.27204806 |
113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26610403 |
114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26337145 |
115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25900318 |
116 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.25713345 |
117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24683510 |
118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24545278 |
119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24228954 |
120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.22956508 |
121 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.21303846 |